Proliferation |
TRMT6, TRMT61A, ALKBH3 |
mRNA |
Promotion |
GI, HCC, Glioma |
Modulation of PI3K/AKT pathway [56], [57], [61]
|
TRMT6, TRMT61A |
tRNAiMet
|
Promotion |
Glioma |
Upregulation of m [1]A58 in tRNAiMet[58]
|
ALKBH3 |
tRNA |
Promotion |
PAAD, OC |
Enhancing protein synthesis by demethylating tRNA [41]Generation of tRNA-derived small RNAs by demethylating tRNA [27]
|
Invasion |
ALKBH3 |
mRNA |
Promotion |
BC, OC |
Promoting translation of m1A-modified CSF-1 mRNA [51]
|
ALKBH3 |
tRNA |
Promotion |
PAAD, OC |
Generation of tRNA-derived small RNAs by demethylating tRNA [27]
|
YTHDF3 |
mRNA |
Suppression |
Trophoblast |
Promoting the mRNA decay of IGF1R mRNA [50]
|
Cancer metabolism |
TRMT6, TRMT61A |
tRNA |
Promotion |
HCC |
Increasing PPARδ translation to stimulate cholesterol synthesis [62]
|
ALKBH3, YTHDF1 |
mRNA |
Promotion |
OC |
Increasing expression of ATP5D mRNA to promote the glycolysis [38]
|
Senescence, cell death |
ALKBH3 |
mRNA |
Promotion |
NSCLC, BLCA |
Increasing the expression of p27 and p21 [65], [66]. |
Tumor microenvironment |
YTHDF3 |
mRNA |
Promotion |
RAW264.7 |
Regulating the macrophage M1 and M2 polarization [70], |